Treatment of murine leukaemia with heterologous antiserum or cyclophosphamide.
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D002460:Cell Line; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000633:toxicity; D007116:Immunization, Passive; D007120:Immunochemistry; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D009052:Leukemia Virus, Murine / Q000187:drug effects*; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000401:mortality; D051379:Mice; D011817:Rabbits; D013154:Spleen; D013950:Thymus Gland
D000961:Antilymphocyte Serum; D003520:Cyclophosphamide